Skip to content

Understanding What Do Older Adults Have an Increased Risk of If They Take Neuroleptics: Stroke, Osteoporosis, Heart Failure, Liver Failure?

3 min read

Recent studies in medical journals highlight the serious side effects associated with antipsychotic medication in seniors. Understanding what do older adults have an increased risk of if they take neuroleptics: stroke, osteoporosis, heart failure, liver failure is crucial for medication safety and senior well-being.

Quick Summary

Older adults, particularly those with dementia, who take neuroleptic medications face a significantly increased risk of adverse cardiovascular events, including stroke and heart failure, as well as an elevated risk of bone fractures and pneumonia. Risks are often highest during the initial phase of treatment.

Key Points

  • Significantly Increased Stroke Risk: Older adults, particularly those with dementia, face a heightened risk of stroke when taking neuroleptics, with the risk being highest in the initial phase of treatment.

  • Cardiovascular Complications are Common: Besides stroke, increased risks of heart failure, myocardial infarction, and arrhythmias are associated with neuroleptic use in the elderly.

  • Osteoporosis and Fractures: Long-term use can reduce bone mineral density via hormonal effects, while sedative side effects increase the risk of falls and resulting fractures.

  • Other Serious Risks: Neuroleptic use is also linked to an increased incidence of pneumonia and kidney injury in older adults.

  • Minimizing Harm: Safe use requires starting at the lowest effective dose for the shortest possible duration, prioritizing non-drug alternatives, and conducting regular patient monitoring.

  • Risk vs. Reward Assessment: Healthcare providers must carefully evaluate the risk-benefit ratio for each individual, considering existing health conditions and comorbidities.

In This Article

The Role of Neuroleptics and Their Use in the Elderly

Neuroleptics, also known as antipsychotic medications, are primarily used to manage symptoms of psychosis, such as hallucinations and delusions. In older adults, especially those with dementia, these drugs are sometimes prescribed off-label for behavioral and psychological symptoms. There are two main types: first-generation (typical) and second-generation (atypical). Despite initial beliefs, atypical neuroleptics also pose significant risks in the elderly. Health regulators have issued a black box warning due to the increased risk of mortality when prescribing neuroleptics to older adults for dementia-related psychosis.

The Prominent Risk of Stroke in Older Adults Taking Neuroleptics

An increased risk of stroke is a well-documented concern for older adults on neuroleptics. Studies show significantly higher stroke odds, especially for those with dementia.

Scientific Findings on Stroke Risk

Research indicates the odds of stroke can be up to 1.8 times higher for older patients on antipsychotics. This risk emerges shortly after starting treatment, peaking within the first week. The elevated risk for ischemic stroke is particularly established.

The Burden of Cardiovascular and Cardiac Events

Neuroleptics also increase the risk of other serious cardiovascular issues, including heart failure. Contributing factors include weight gain and effects on heart function.

  • Heart Failure: An increased risk of heart failure has been observed in older adults using neuroleptics.
  • Other Serious Cardiac Events: Typical neuroleptics have been linked to a moderately increased risk of serious cardiac events like heart attack and arrhythmias in older adults. Close cardiovascular monitoring is essential.

Musculoskeletal and Other Major Side Effects

Neuroleptics are associated with other serious health problems in older patients, including osteoporosis and fractures.

Osteoporosis and Fracture Risk

Prolonged neuroleptic use can negatively impact bone health.

  • Reduced Bone Mineral Density: Some atypical neuroleptics can increase prolactin, suppressing hormones that maintain bone density, leading to osteoporosis risk.
  • Increased Fall Risk: Side effects like sedation and unsteadiness increase fall risk and subsequent fractures.

Pneumonia and Kidney Injury

Older adults on neuroleptics also have a significantly increased risk of pneumonia and acute kidney injury.

Hepatotoxicity and Liver Effects

While less frequent than cardiovascular events, liver injury is a potential side effect.

  • Risk Profile: The risk varies by drug; some like chlorpromazine and clozapine have a higher risk, while others like aripiprazole have a lower risk.
  • Monitoring: Liver function monitoring is advised for those on higher-risk agents to detect issues early.

Comparison of Key Risks Associated with Neuroleptic Use in Older Adults

Below is a summary of the main risks:

Health Condition Associated with Neuroleptic Use in Older Adults? Risk Level Notable Considerations
Stroke Yes Significantly Increased Especially in dementia; highest shortly after starting.
Heart Failure Yes Increased Linked to metabolic/cardiovascular effects.
Osteoporosis Yes Increased (Long-term) Due to hormonal changes and increased falls.
Liver Failure Yes (Rare) Low to Moderate Risk varies by drug.
Fractures Yes Increased Linked to increased fall risk from side effects.
Pneumonia Yes Increased Higher infection incidence, particularly in dementia.

Managing Risk and Exploring Alternatives

Given the risks, a cautious approach is vital.

  • Non-Pharmacological Interventions: For conditions like BPSD in dementia, non-drug methods like music therapy and personalized care are safer first options.
  • Lowest Effective Dose: If neuroleptics are necessary, use the lowest dose for the shortest time, with regular monitoring.
  • Careful Evaluation: Clinicians should carefully assess risks vs. benefits, considering existing health conditions.
  • Monitoring and Review: Ongoing monitoring for side effects is crucial. Treatment should be reviewed regularly, and withdrawal considered if benefits don't outweigh risks.

For further information on balancing these medications with patient safety, refer to guidelines from the National Institute for Health and Care Excellence (NICE) regarding antipsychotics in dementia Read more here.

Conclusion

While neuroleptics can be useful, their use in older adults, especially those with dementia, significantly increases the risk of serious issues like stroke, heart failure, and fractures. A cautious approach, prioritizing non-drug options and using the lowest possible dose for the shortest duration when medication is necessary, is critical for safety.

Frequently Asked Questions

Older adults are generally more vulnerable due to age-related changes in metabolism, drug sensitivity, and the presence of other health conditions (comorbidities). This can lead to higher blood concentrations of the drug and an increased risk of adverse effects like stroke and sedation.

The black box warning is a serious alert issued by health regulators, noting that elderly patients with dementia-related psychosis who are treated with antipsychotic drugs have an increased risk of death compared to a placebo. This highlights the serious risk associated with these medications in this specific population.

While both typical and atypical neuroleptics have been associated with an increased risk of stroke in older adults, studies suggest the risk is particularly high in the initial phase of treatment with most antipsychotic agents. The overall risk is significant enough to warrant caution across the board.

Yes, many non-pharmacological interventions are available and often safer. These include structured activities, music therapy, social interaction, aromatherapy, personalized care plans, and creating a calm, supportive environment. These should be tried before considering medication.

Neuroleptics can increase fracture risk in two main ways: by causing hormonal changes that weaken bones (reduced bone mineral density or osteoporosis) and by inducing side effects like sedation, dizziness, and unsteadiness that increase the likelihood of falls. Increased prolactin can lead to hormonal imbalances affecting bone density.

Regular monitoring for cardiovascular health (blood pressure, heart function), metabolic changes (weight, blood sugar), and cognitive function is recommended. Liver function monitoring is also important, especially when using higher-risk agents. Additionally, evaluating for changes in mobility, balance, and signs of tardive dyskinesia is crucial.

While liver damage is rare, risk can be minimized by careful drug selection, especially avoiding higher-risk agents if possible. Counseling patients on symptoms of liver injury (e.g., jaundice, abdominal pain) and regular lab monitoring, especially for those initiating treatment, is vital.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.